BDBM557850 6-((1-acryloylpiperidin-4-yl)oxy)-4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxy-quinoline-3-carbonitrile::US11365189, Ex. No. 4

SMILES COC1=CC2N=CC(C#N)=C(Nc3ccc(Cl)c(Cl)c3F)C2C=C1OC1CCN(CC1)C(=O)C=C

InChI Key InChIKey=CMWHBLTWQKOFFI-UHFFFAOYSA-N

Data  10 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 557850   

TargetReceptor tyrosine-protein kinase erbB-2 [1-775,'YVMA',776-1255](Human)
University Of Texas

US Patent
LigandPNGBDBM557850(US11365189, Ex. No. 4 | 6-((1-acryloylpiperidin-4-...)
Affinity DataIC50: 30nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [1-780,'GSP',781-1255](Human)
University Of Texas

US Patent
LigandPNGBDBM557850(US11365189, Ex. No. 4 | 6-((1-acryloylpiperidin-4-...)
Affinity DataIC50: 25nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255](Human)
University Of Texas

US Patent
LigandPNGBDBM557850(US11365189, Ex. No. 4 | 6-((1-acryloylpiperidin-4-...)
Affinity DataIC50: 47nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor(Human)
University Of Texas

US Patent
LigandPNGBDBM557850(US11365189, Ex. No. 4 | 6-((1-acryloylpiperidin-4-...)
Affinity DataIC50: 60nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [S768I](Human)
University Of Texas

US Patent
LigandPNGBDBM557850(US11365189, Ex. No. 4 | 6-((1-acryloylpiperidin-4-...)
Affinity DataIC50: 0.130nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-770,'SVD',771-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557850(US11365189, Ex. No. 4 | 6-((1-acryloylpiperidin-4-...)
Affinity DataIC50: 10nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-770,'NPG',771-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557850(US11365189, Ex. No. 4 | 6-((1-acryloylpiperidin-4-...)
Affinity DataIC50: 7.20nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-769,'SVD',770-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557850(US11365189, Ex. No. 4 | 6-((1-acryloylpiperidin-4-...)
Affinity DataIC50: 10nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-769,'SV',770-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557850(US11365189, Ex. No. 4 | 6-((1-acryloylpiperidin-4-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557850(US11365189, Ex. No. 4 | 6-((1-acryloylpiperidin-4-...)
Affinity DataIC50: 5.90nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent